Cargando…
MiR‐873 inhibition enhances gefitinib resistance in non‐small cell lung cancer cells by targeting glioma‐associated oncogene homolog 1
BACKGROUND: The five‐year survival rate of non‐small cell lung cancer (NSCLC) patients is very low. MiR‐873 is involved in the growth, metastasis, and differentiation of tumors. Herein, we determined the target gene and influence of miR‐873 in NSCLC. METHODS: MiRanda and Targetscan websites were use...
Autores principales: | Jin, Shidai, He, Jing, Li, Jun, Guo, Renhua, Shu, Yongqian, Liu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166090/ https://www.ncbi.nlm.nih.gov/pubmed/30126075 http://dx.doi.org/10.1111/1759-7714.12830 |
Ejemplares similares
-
STRA6 exerts oncogenic role in gastric tumorigenesis by acting as a crucial target of miR-873
por: Lin, Linling, et al.
Publicado: (2019) -
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
por: Gao, Lanlan, et al.
Publicado: (2019) -
Long non-coding RNA LOC554202 promotes acquired gefitinib resistance in non-small cell lung cancer through upregulating miR-31 expression
por: He, Jing, et al.
Publicado: (2019) -
miR-873 and miR-105-2 May Affect the Tumour Microenvironment and are Potential Biomarkers for Lung Adenocarcinoma
por: Zhang, Hao, et al.
Publicado: (2022) -
miR-873 inhibits colorectal cancer cell proliferation by targeting TRAF5 and TAB1
por: Gong, Hui, et al.
Publicado: (2018)